Skip to main content

4 Result(s)

within Fatemeh Vazirian Remove this filter

and

  1. Article

    Open Access

    Non-HDL cholesterol and long-term follow-up outcomes in patients with metabolic syndrome

    Non-high-density lipoprotein-cholesterol (non-HDL-C) has been identified as a potential biomarker for metabolic syndrome (MetS). However, its predictive capability for MetS varies among different ethnic groups...

    Fatemeh Vazirian, Susan Darroudi, Hamid Reza Rahimi… in Lipids in Health and Disease (2023)

    Download PDF (1265 KB) View Article

  2. Article

    Open Access

    Correlation between osteoprotegerin and coronary artery calcification in diabetic subjects: a systematic review of observational studies

    Coronary artery calcification (CAC) is one of the critical cardiovascular complications that lead to elevated morbidity and mortality among patients with type 2 diabetes (T2M). The association between osteopro...

    Fatemeh Vazirian, Masoumeh Sadeghi, Dongdong Wang… in BMC Cardiovascular Disorders (2023)

    Download PDF (1090 KB) View Article

  3. No Access

    Article

    Evaluation of the efficacy of Thymus kotschyanus extract as an additive treatment in patients with ulcerative colitis: a randomized double-blind placebo-controlled trial

    Ulcerative colitis (UC) is one of the chronic diseases which is increasing in prevalence and patients suffer from illness flare-ups. UC standard regimen treatment has various side effects besides the efficacy,...

    Fatemeh Vazirian, Sara Samadi, Mohammadreza Abbaspour… in Inflammopharmacology (2022)

  4. No Access

    Article

    Aprepitant, fosaprepitant and risk of ifosfamide-induced neurotoxicity: a systematic review

    Ifosfamide is one of the chemotherapy regimens which potentially causes neurotoxicity in patients up to 30%. Aprepitant is administered as an anti-emetic agent in chemotherapy and regarding the inhibitory effe...

    Fatemeh Vazirian, Sara Samadi, Hossein Rahimi… in Cancer Chemotherapy and Pharmacology (2022)